• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    EMA gives positive opinion to Fexinidazole as first oral treatment of rhodesiense

    PRESS RELEASE

    Sanofi gets positive EMA opinion for sleeping sickness treatment

    REUTERS

    USFDA approves fexinidazole as first all-oral treatment for sleeping sickness

    CONTAGIONLIVE

    CHMP recommends first oral-only treatment for sleeping sickness

    EMA

    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18

    EMA

    Sanofi teams with non-profit on a landmark new drug for sleeping sickness

    ENDPTS

    Sanofi, DNDi seek EMA review for sleeping sickness drug

    PHARMA TIMES

    Sanofi, DNDi seek EMA review for fexinidazole to treat sleeping sickness

    PHARMABIZ

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.